Circulating 25-Hydroxyvitamin D,VDRPolymorphisms, and Survival in Advanced Non–Small-Cell Lung Cancer

Journal of Clinical Oncology - United States
doi 10.1200/jco.2008.18.0406
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

The Relationship Between Circulating 25-Hydroxyvitamin D and Survival in Newly Diagnosed Advanced Non-Small-Cell Lung Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Circulating Microparticles Are Prognostic Biomarkers in Advanced Non-Small Cell Lung Cancer Patients

Oncotarget
Oncology
2017English

Genetic Polymorphisms in the Vitamin D Pathway and Non-Small Cell Lung Cancer Survival

Pathology and Oncology Research
MedicineForensic MedicinePathologyOncologyCancer Research
2019English

Afatinib Treatment in Advanced Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2011English

Maintenance Therapy Improves Survival Outcomes in Patients With Advanced Non-Small Cell Lung Cancer

Lung
PulmonaryRespiratory Medicine
2015English

CPC-017 Analysis of Survival in Patients With Advanced Non-Small Cell Lung Cancer

European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
2013English

Advanced Non-Small Cell Lung Cancer in Elderly Patients

Breathe
PulmonaryRespiratory Medicine
2012English

Modeling Tumor Dynamics and Overall Survival in Advanced Non–Small-Cell Lung Cancer Treated With Erlotinib

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

Circulating Nucleosomes Predict the Response to Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy